期刊文献+

铁超载与非酒精性脂肪性肝病的关系及其作用机制的研究进展 被引量:1

Relationship between iron overload and nonalcoholic fatty liver disease: An update
下载PDF
导出
摘要 作为多重打击的一部分,铁超载在非酒精性脂肪性肝病(nonalcoholic fatty liver disease,N A F L D)的发生发展过程中起到重要作用.铁超载影响机体的糖、脂、能量代谢以及炎症反应.因此本文就铁超载与NAFLD的关系加以综述,以期能阐明铁超载对NAFLD的代谢调节机制. As a component of the multiple hits, iron overload plays an important role in the development of nonalcoholic fatty liver disease(NAFLD). Iron overload could affect glucose, lipid, energy metabolism and inflammatory reaction. This paper reviews the relationship between iron overload and nonalcoholic fatty liver disease, in order to clarify how and why iron overload influences the progression of NAFLD.
出处 《世界华人消化杂志》 CAS 2016年第22期3398-3403,共6页 World Chinese Journal of Digestology
基金 国家自然科学基金资助项目 Nos.81273727 81302927 上海市教委科研创新一般基金资助项目 No.14YZ054~~
关键词 铁超载 非酒精性脂肪性肝病 氧化应激 糖脂代谢 Iron overload Non-alcoholic fatty liver disease Oxidative stress Glucose and lipid metabolism
  • 相关文献

参考文献6

二级参考文献70

  • 1Ajay Duseja,Reena Das,Mohit Nanda,Ashim Das,Gurjeewan Garewal,Yogesh Chawla.Nonalcoholic steatohepatitis in Asian Indians is neither associated with iron overload nor with HFE gene mutations[J].World Journal of Gastroenterology,2005,11(3):393-395. 被引量:9
  • 2杨月欣.中国食物成分表2004[M].北京:北京大学医学出版社,2006.213.
  • 3Kowdley KV, Belt P, Wilson LA, Yeh MM, Neuschwander- Tetri BA, Chalasani N, Sanyal AJ, Nelson JE. Serum fer- ritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease. Hepatology 2012; 55:77-85.
  • 4Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001; 50:1844-1850.
  • 5Day CP. From fat to inflammation. Gastroenterology 2006; 130:207-210.
  • 6Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, Carucci P, Musso A, De Paolis P, Capussotti L, Salizzoni M, Rizzetto M. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterolo/2002; 123:134-140.
  • 7Musso G, Gambino R, Cassader M, Pagano G. Meta- analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 2011; 43:617-649.
  • 8Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004; 40:1387-1395.
  • 9Bellentani S, Saccoccio G, Masutti F, Croc LS, Brandi G, Sasso F, Cristanini G, Tiribelli C. Prevalence of and risk fac- tors for hepatic steatosis in Northern Italy. Ann Intern Med 2000; 132:112-117.
  • 10Sanyal AJ, Chalasani N, Kowdley KV, McCullough A, Diehl AM, Bass NM, Neuschwander-Tetri BA, Lavine JE, Tonas- cia J, Unalp A, Van Natta M, Clark J, Brunt EM, Kleiner DE, Hoofnagle JH, Robuck PR. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med 2010;362:1675-1685.

共引文献48

同被引文献5

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部